Package 68001-313-56

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 68001-313-56
Digits Only 6800131356
Product NDC 68001-313
Product ID 68001-313_36080e4e-a0fe-ba15-e063-6394a90aed5c
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68001-313-56)

Marketing

Marketing Status
Discontinued 2026-12-31
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "36080e4e-a0fe-ba15-e063-6394a90aed5c", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0368001313568"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68001-313-56)", "package_ndc": "68001-313-56", "marketing_end_date": "20261231", "marketing_start_date": "20170701"}], "brand_name": "Azacitidine", "product_id": "68001-313_36080e4e-a0fe-ba15-e063-6394a90aed5c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-313", "generic_name": "Azacitidine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "NDA208216", "marketing_category": "NDA", "marketing_end_date": "20261231", "marketing_start_date": "20170701"}